Summary

The CREDENCE trial found that Cleerly ISCHEMIA provided superior diagnostic accuracy and performance compared to FFRCT and traditional stress testing, when benchmarked against 868 invasive FFR measurements. This software accurately assesses atherosclerosis by analyzing plaque volume, composition, and location, and evaluates stenosis severity using both 2D and 3D measurements, ultimately aiding in determining ischemia and potentially minimizing the need for further invasive procedures.

Title

Personalized Analysis and Treatment of Heart Disease | Cleerly

Description

Cleerly determines your risk of heart attack by performing a non-invasive whole heart assessment to identify, characterize, and quantify plaque buildup.

Keywords

ischemia, demo, more, request, providers, patients, plaque, analysis, billing, guidelines, blog, patient, products, events, coverage, contact, solution

Upstreams

cholesterolcode.com

NS Lookup

A 199.60.103.33, A 199.60.103.133

Dates

Created 2024-11-29

Updated 2026-02-09

Summarized 2026-03-12